drugset / Trial / NCT06701305
A Study of Efinopegdutide in Healthy Obese Participants (MK-6024-015)
RandomizedParallel-groupDouble-blindBasic science
Summary
The goal of this study is to learn about the safety of efinopegdutide (MK-6024) and how well overweight healthy people tolerate it. Researchers also want to know what happens to efinopegdutide in a person's body over time when taken as a single dose (Part 1) or as multiple doses (Part 2). In addition, the study will assess the amount of acetaminophen in the blood after receiving different strength doses of efinopegdutide (Part 2 only).
Timeline
- Start
- 2024-06-13
- Primary completion
- 2025-02-18
- Completion
- 2025-02-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acetaminophen | Small molecule | — | Oral |
| Subject | JNJ-64565111 | Unknown | — | Subcutaneous |
Indications
No indication recorded.